Leading generics pharmaceutical company
Media
Navigating the Future of Pharmaceuticals: Unveiling the Power of Pharma Contract Manufacturing with Taj Pharmaceuticals In the dynamic world of pharmaceuticals, the practice of Pharma Contract Manufacturing has emerged as a game-changing strategy, breathing new life into the industry. At the forefront of this transformation is Taj Pharmaceuticals, a name synonymous with innovation, collaboration, and […]
In the era of pharmaceuticals, precision and innovation converge to produce medical marvels that shape the healthcare landscape. Amidst this arena, Taj Pharmaceuticals emerges as a trailblazing force, redefining the parameters of quality and excellence in the realm of Lyophilized Injection products. This article delves deep into the facets that set Taj Pharmaceuticals apart, exploring […]
The enforcement by the drug regulator will not be easy given the shortage of drug inspectors – {Taj Generic Drug Division} Prime Minister Narendra Modi wants to defeat the doctor-pharmaceutical company nexus and make medicines affordable by making it compulsory to prescribe drugs in the generic name. But, the good intentions may not give the […]
There is a question about what role race and wealth play in how much attention and funding the disease receives. Sickle cell disease affects about 100,000 Americans, most of them African-Americans. There are few treatments for it, and experts say not enough is being done to prevent complications. Just recently, the Centers for Medicare […]
With the outbreak of coronavirus infection, people are now being advised to wear surgical masks for protection. Surgical masks are easily available in the market. Experts suggest using surgical masks to protect yourself from harmful airborne bacteria and virus particles, keeping flu at bay. A surgical mask is different from the anti-pollution P-rated or N-rated […]
Latest Mediscor review says generic utilisation rate more than doubled from 27.7% in 2002 to 62.4% in 2018 The use of cheaper generic alternatives that are no longer patent-protected rose to an all-time high in the private sector in 2018, according to the latest Mediscor review. The trend highlights the continued impact of the […]
As per the study conducted by Journal of Drug Delivery and Therapeutics, about 62% of healthcare providers want to substitute generic drugs but not for all the cases they treat, thus indicates the perception of the efficacy of the two classes of medicines. With the escalating cost of healthcare facilities, many people in India […]
India has decided to rethink which medicines can and can’t be sold without prescriptions. These measures will finally create a definition for over the counter (OTC) drugs and possibly curb the sale of some dangerous medicines. So what separates OTC drugs from prescription-only and why is this categorisation so important? In November 2016, India’s drug […]
Date: March 5, 2019 In a move to promote low-cost generic medicines, the government plans to color code such drugs to enable consumers to differentiate between generic medicines and other drugs and take an informed decision while purchasing them from chemists. Apart from color coding, the government is also considering use of symbols to […]
Medicare could have saved nearly 90% of spending on angiotensin converting enzyme inhibitors and angiotensin-II-receptor blockers in 2016 and 2017 through generic substitute or therapeutic interchange, according to study results published in JAMA Internal Medicine. “Prescription drug spending accounts for an increasing share of U.S. health care costs.” Mathew E. Growdon, MD, MPH, of the […]
Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC. SPC’s are defined as IP rights extending patent protection for up to five years for medicines that are […]
“Costly branded medicines are a factor in driving up the cost of insurance”! Expensive branded medicines prescribed by doctors are driving up the cost of healthcare for insurers and employers, experts have said. Insurers said too many physicians are sending patients home with bags of unnecessary drugs. The issue is a factor in a new […]
It’s pretty much just two women who name the 200-plus drugs that come out every year Generic prescriptions allow patients to get the medicines they need at a lower price, without sacrificing the quality of treatment because, as we know, generic drugs are required by the FDA to be nearly identical to their name-brand […]
BARCELONA — In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organization funded primarily by Unitaid to increase access to medicines in lower-income countries, signed two voluntary licensing agreements. The agreements allowed generic manufacturers to produce and sell low-cost versions of the ViiV-developed HIV drug dolutegravir in all low- […]
According to the Association for Accessible Medicines 2019 report with data from IQVIA, generic drug savings totaled $293 billion in 2018, which resulted in a 10-year savings of almost $2 trillion. Other key findings include that 4 billion generic prescriptions were filled across the U.S. in 2018, which is 90% of all dispensed prescriptions. Additionally, 95% of […]
According to the World Health Organization, sham drugs are the world’s most lucrative counterfeit goods, with a global market worth roughly $200bn, and Africa accounts for around 42% of the world’s cases. But what is behind this scourge, and what can be done to stop it? Abi Miller finds out. Counterfeit drugs are a deadly, […]
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. Amid a raging controversy over commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited today said that its formulation drug is safe. The company said that the test results found that Taj Pharmaceuticals’ Ranitidine tablets was within […]
A nationwide shortage of a generic drug that can shrink and control brain tumors in children raises questions about how critical medicines can go scarce. Life-saving pediatric cancer drugs are frequently unavailable due to shortages. Since being diagnosed with a brain tumor nearly a year ago, my son has lived much like any 5-year-old – in […]
WHO chief on Monday urged for an increase in production of steroid dexamethasone to treat the critically-ill Covid-19 patients. Taj Pharmaceuticals, the well-known Dexamethasone Tablets API Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard.
Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone.[1] In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.
Compassionate use allows very sick people to get access to treatments that might help Covid-19, but it’s not without problems #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
The WHO said there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. The World Health Organization issued a warning Friday about coronavirus testing, saying there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Medical News, Press Release
The latest on the potential Covid-19 treatment under research. A daily Covid-19 update from {Taj Pharmaceuticals Limited} Coronavirus Latest Breaking News, Coronavirus Treatments, Coronavirus Clinical Trials, and Special Reports on COVID-19.
A woman takes a swab test for the virus. Credit: ITV News Central The government has been under fire for several days now about the rate of testing for Coronavirus, especially among front-line heath workers.
